The value of the Brazilian açai fruit as a therapeutic nutritional strategy for chronic kidney disease patients

Açai ( Euterpe oleracea Mart.) fruit from the Amazon region in Brazil contains bioactive compounds such as α-tocopherol, anthocyanins (cyanidin 3-glycoside and cyanidin 3-rutinoside), and other flavonoids with antioxidant and anti-inflammatory properties. Moreover, the prebiotic activity of anthocya...

Full description

Saved in:
Bibliographic Details
Published in:International urology and nephrology Vol. 50; no. 12; pp. 2207 - 2220
Main Authors: Martins, Isabelle C. V. S., Borges, Natália A., Stenvinkel, Peter, Lindholm, Bengt, Rogez, Hervé, Pinheiro, Maria C. N., Nascimento, José L. M., Mafra, Denise
Format: Journal Article
Language:English
Published: Dordrecht Springer Netherlands 01-12-2018
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Açai ( Euterpe oleracea Mart.) fruit from the Amazon region in Brazil contains bioactive compounds such as α-tocopherol, anthocyanins (cyanidin 3-glycoside and cyanidin 3-rutinoside), and other flavonoids with antioxidant and anti-inflammatory properties. Moreover, the prebiotic activity of anthocyanins in modulating the composition of gut microbiota has emerged as an additional mechanism by which anthocyanins exert health-promoting effects. Açai consumption may be a nutritional therapeutic strategy for chronic kidney disease (CKD) patients since these patients present with oxidative stress, inflammation, and dysbiosis. However, the ability of açai to modulate these conditions has not been studied in CKD, and this review presents recent information about açai and its possible therapeutic effects in CKD.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0301-1623
1573-2584
1573-2584
DOI:10.1007/s11255-018-1912-z